跳转至内容
Merck
CN
所有图片(2)

文件

安全信息

HCVD1MAG-67K

Millipore

MILLIPLEX® 人心血管疾病（CVD）磁珠板1 - 心血管疾病多重检测

The analytes available for this multiplex kit are: BNP, NT-proBNP, CK-MB, CXCL6/GCP-2, CXCL16, Endocan-1 (ESM-1), FABP3, FABP4, LIGHT, Oncostatin (OSM), Placental Growth Factor (PlGF), Troponin I (TnI).

登录查看公司和协议定价
所有图片(2)

About This Item

UNSPSC代码:
12161503
eCl@ss:
32161000
NACRES:
NA.84

质量水平

200

种属反应性

human

制造商/商品名称

Milliplex®

assay range

accuracy: 100%
(CK-MB)
accuracy: 102%
(LIGHT)
accuracy: 102%
(Oncostatin (OSM))
accuracy: 103%
(CXCL6/GCP-2)
accuracy: 96%
(FABP3)
accuracy: 96%
(Placental Growth Factor (PlGF))
accuracy: 97%
(NT proBNP)
standard curve range: 137.2-100,000 pg/mL
(FABP3)
standard curve range: 2.7-2,000 pg/mL
(Placental Growth Factor (PlGF))
standard curve range: 34.3-25,000 pg/mL
(NT proBNP, CXCL16, Endocan-1 (ESM-1), LIGHT)
standard curve range: 6.9-5,000 pg/mL
(CXCL6, Oncostatin (OSM))
standard curve range: 68.6-50,000 pg/mL
(BNP, CK-MB, Troponin I (TnI))
standard curve range: 685.9-500,000 pg/mL
(FABP4)
inter-assay cv: <20%
intra-assay cv: <10%

技术

multiplexing: suitable

检测方法

fluorometric (Luminex xMAP)

运输

wet ice

相关类别

一般描述

心血管疾病，特别是动脉粥样硬化性血管疾病，是全球死亡的主要原因，占全部全球死亡的30%（WHO，2010）。 炎症机制在血管疾病的发生、维持和进展中起着至关重要的作用，炎症标志物与急性和慢性冠状动脉疾病的预后之间具有强烈的相关性。大量研究表明肥胖和糖尿病与心血管风险因子具有关联性。

MILLIPLEX®人类心血管疾病（CVD）面板1是一种12重试剂盒，用于同时定量人血清、血浆或组织/细胞裂解物和培养上清液样品中以下分析物的任何或全部：BNP，NTproBNP，CK-MB，CXCL6，CXCL16，Endocan-1（ESM-1），FABP3，FABP4，LIGHT，抑瘤素M（OSM），胎盘生长因子（PlGF）和肌钙蛋白I。该试剂盒采用96孔板，包含冻干标准混合物、两个内部检测质控品，可最多可测定38份样本，重复两次。

Luminex® xMAP®平台使用磁珠免疫分析格式，以实现理想的速度和灵敏度，同时定量多种分析物，从而显著提高生产力，同时节省宝贵的样本量。

面板类型：心血管

特异性

交叉反应性
对于该面板中的一种分析物和任何其他分析物，抗体之间没有或有可以忽略不计的交叉反应性。

应用

  • 分析物：BNP，CK-MB，CXCL6/GCP-2，CXCL16，Endocan-1（ESM-1），FABP3，FABP4，LIGHT，NT-proBNP，抑瘤素M（OSM），胎盘生长因子（PlGF）和肌钙蛋白I（TnI）
  • 推荐的样品类型：人血清，血浆或组织/细胞培养上清液和裂解液
  • 推荐的样本稀释度：每孔25 μL未稀释的血清或血浆；组织/细胞培养样品可能需要在适当的对照培养基中稀释
  • 分析运行时间：在2-8℃下过夜（16-18小时）
  • 研究类别：心血管疾病
  • 研究子类别：代谢紊乱

特点和优势

通过在此面板中选择可用的分析物来设计多重试剂盒。

其他说明

灵敏度：有关单个分析物灵敏度’，请参见试剂盒方案。
请联系技术服务部进行稀释度线性研究。

法律信息

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

免责声明

除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

警示用语：

Danger

危险分类

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

靶器官

Respiratory Tract

储存分类代码

10 - Combustible liquids

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Andrew J Swift et al.
Thorax, 76(10), 1032-1035 (2021-02-27)
End points that are repeatable and sensitive to change are important in pulmonary arterial hypertension (PAH) for clinical practice and trials of new therapies. In 42 patients with PAH, test-retest repeatability was assessed using the intraclass correlation coefficient and treatment
Luca Di Antonio et al.
Scientific reports, 8(1), 15631-15631 (2018-10-26)
The aim of the study was to assess retinal vascular changes using optical coherence tomography angiography (OCTA) and aqueous humour changes of vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) levels in treatment-naïve myopic choroidal neovascularization (mCNV) after
Kévin Contrepois et al.
Cell, 181(5), 1112-1130 (2020-05-30)
Acute physical activity leads to several changes in metabolic, cardiovascular, and immune pathways. Although studies have examined selected changes in these pathways, the system-wide molecular response to an acute bout of exercise has not been fully characterized. We performed longitudinal
Li-Rong Yu et al.
Experimental biology and medicine (Maywood, N.J.), 243(3), 248-255 (2017-12-12)
Cancer treatment with doxorubicin (DOX) can induce cumulative dose-dependent cardiotoxicity. Currently, there are no specific biomarkers that can identify patients at risk during the initial doses of chemotherapy. The aim of this study was to examine plasma cytokines/chemokines and potential
Seungwon An et al.
The ocular surface, 17(3), 589-614 (2019-04-10)
To investigate the role of neutrophil extracellular traps (NETs) and NET-associated proteins in the pathogenesis of oGVHD and whether dismantling of NETs with heparin reduces those changes. Ocular surface washings from oGVHD patients and healthy subjects were analyzed. Isolated peripheral
查看所有相关文献

相关内容

Multiplex CVD Biomarker Measurement

Multiplex CVD panels like MILLIPLEX® assays enhance biomarker discovery for cardiovascular disease research.

MILLIPLEX® PLEXpedition Multiplex Biomarker Screening Panel

Simplify protein biomarker discovery with the MILLIPLEX® PLEXpedition 115-Plex Multiplex Screening Panel. Effortlessly screen cytokines and other markers with Luminex® technology.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门